Figure S1
Epitope mapping of PrP res from voles infected with GSS A117V. Neuropathology and PrP res after second passage of GSS A117V cases in Bv109I.
Replica blots of PrP
Hippocampal sections from representative Bv109I after second passage of GSS A117V case #1 (a, c, e, g) and case #2 (b, d, f, h) were stained with haematoxilin and eosin (a, b, c, d) or analysed by IHC for PrP with mAb 6C2 (e, f, g, h). The neuropathological patterns observed were indistinguishable from those observed after primary passage (see Fig. 1 ). i, PET blot from a representative Bv109I after second passage of GSS A117V case #1. l, comparison of PrP res from
Bv109I after primary transmission (lane 1) or second passage (lanes 2-4) of GSS A117V case #1.
The blot was probed with mAb 9A2.
Figure S3
Comparison of PrP res in the GSS inocula.
The inocula prepared from all GSS cases (indicated on the top of each lane according to Table 1) were compared for their PrP res content. The inocula (10% brain homogenates in PBS) were added with an equal volume of 100 mM Tris-HCl containing 4% sarkosyl, treated with 100 µg/ml PK, added with an equal volume of isopropanol/butanol (1:1 v/v) and centrifuged at 20000 g for 5 min.
The supernatants were discarded and the pellets were dissolved in denaturing sample buffer for WB analysis. All samples were loaded as 1,5 mg brain equivalent per lane. The blot was probed with mAb 9A2. Figure S4 PET blot analysis of PrP Sc from a Bv109I inoculated with frontal cortex from GSS P102L case #6 which accumulated 21 kDa PrP res . Cortical (a) and hippocampal (b) sections show either diffuse PrP Sc deposition and PrP Sc plaques, whose distribution is similar to that observed by IHC in the same brain areas (see Fig. 3 ). The blot was probed with mAb 6C2.
